纳斯达克生物科技指数跌超1%，表现逊色于美国三大股指

成分股中，Lyell Immunopharma跌10.28%表现最差，Codexis和Acumen Pharmaceuticals至多跌7.58%，Fate Therapeutics跌6.78%，Aclaris Therapeutics、Seres Therapeutics、NGM Biopharma跌幅介于5.90%-5.64%，Alx Oncology Holdings、内克塔治疗（NKTR）、Sangamo Therapeutics、 MeiraGTx、SIGA Tech、Verve Therapeutics、莫德纳（MRNA）、Veracyte、Editas Medicine跌幅介于4.87%-4.00%。Twist Bioscience、Greenlight Biosciences Holdings PBC则至多涨4.23%，Terns Pharmaceuticalshe Cue Health至多涨5.73%，Monte Rosa Therapeutics、Recursion Pharmaceuticals、Axsome Therapeutics涨6.08%-6.67%，Humacyte涨9.11%，NantKwest涨14.17%，ANI Pharmaceuticals涨16.33%领跑。